Attention Deficit Hyperactivity Disorder (ADHD)

DBCOND0041782Congenital, Hereditary, and Neonatal Diseases and AbnormalitiesMental Disorders

Attention Deficit Hyperactivity Disorder (ADHD) is the indication for 17 drugs in DrugBank. It is covered by 30 curated, structured indications.

Also known as
Attention Deficit Hyperactivity Disorder · Attention Deficit Disorder With Hyperactivity · ADHD NOS · Attention-Deficit/Hyperactivity Disorder · Attention Deficit/Hyperactivity Disorder
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0001943ICD-10F90SNOMED CT154940006MedDRA10001119UMLSC1263846

What you can answer from here — as of September 29, 2026

17Indicated drugsWith each drug's targets and mechanism
Listed above
30Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
740Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Boxed warningLabel boxed warnings that name this condition
Sign in
9Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Attention Deficit Hyperactivity Disorder (ADHD) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In